Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Upstream Bio
Watchlist
Upstream Bio Valuation Summary, DCF Analysis Suggests U.S. Business (Ex. COPD) Is Worth ~$1.8B
Equity Capital Markets
489 Views
28 Sep 2024 17:41
In my insight, I discuss DCF valuation for biotech company Upstream Bio ahead of upcoming IPO, which is expected to be priced in October
What is covered in the Full Insight:
Introduction
IPO Summary
Verekitug Competitive Landscape
Revenue Projections
DCF Analysis
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Japan
India
Sell / Short Ideas
Equity Bottom-Up
Event-Driven
Philippines
South Korea
Unpaywalled Insights
China
Trending Insights
More »
LQ45 Index Rebalance Preview (Jul 2025): Identifying Potential Index Changes
[Quiddity Index] Van Eck Gold Miners ETF (GDX) - Benchmark Change for Sep Rebal - $2.8bn One Way
SM Investments Placement: Large Deal to Digest
[Japan M&A] Polaris MBO for DD Group (3073) - Too Light But Probably a Done Deal
HK-Listed Apparel & Footwear Screener July 2025: August 1st Deadline Approaches
Top Unpaywalled Insights
More »
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Upstream Bio Valuation Summary, DCF Analysis Suggests U.S. Business (Ex. COPD) Is Worth ~$1.8B
28 Sep 2024
Upstream Bio IPO Preview: Severe Asthma/CRSwNP Program Advancing
24 Sep 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x